Clinical features of polyarteritis nodosa in Korea

Journal of Korean Medical Science

Volumn 21, Issue 4, 2006, Pages 591-595

  Young, Deok Bae ^a   Hyo, Jin Choi ^c   Jung, Chan Lee ^c   Jeong, Jin Park ^b   Yun, Jong Lee ^c   Eun, Bong Lee ^c   Yeong, Wook Song ^c,d  

^a Hallym University   (South Korea)

^b Gyeongsang National University   (South Korea)

^c Seoul National University Hospital   (South Korea)

^d Seoul National University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33746896151     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.4.591     Document Type: Article

References (32)

1. Lightfoot RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT, Masi AT, Mills JA, Stevens MB, Wallace SL. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 1990; 33: 1088-93.
2. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, Hagen EC, Hoffman GS, Hunder GG, Kallenberg CG, Mccluskey RT, Sinico RA, Rees AJ, Es La, Waldherr R, Wiik A. Nomenclature of systemic vasculitides. Proposal of an international consensus conference. Arthritis Rheum 1994; 37: 187-92.
3. Lee CW, Kim YJ, Park MH. Clinical features of cutaneous polyarteritis nodosa. Korean J Dermatol 1995; 33: 225-31.
4. Yoon CH, Lee CW. Clinical patterns of cutaneous lesions on the legs in patients with cutaneous polyarteritis nodosa. Korean J Dermatol 2003; 41: 869-72.
5. Guillevin L, Le Thi Huong D, Godeau P, Jais P, Wechsler B. Clinical findings and prognosis of polyarteritis nodosa and Churg-Strauss angiitis: a study in 165 patients. Br J Rheumatol 1988; 27: 258-64.
6. Guillevin L, Lhote F, Gayraud M, Cohen P, Jarrousse B, Lortholary O, Lortholary O, Thibult N, Casassus P. Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 1996; 75: 17-28.
7. Guillevin L, Lhote F. Classification and management of necrotizing vasculitides. Drugs 1997; 53: 805-16.
8. Cohen RD, Conn DL, Ilstrup DM. Clinical features, prognosis, and response to treatment in polyarteritis. Mayo Clin Proc 1980; 55: 146-55.
9. Fortin PR, Larson MG, Watters AK, Yeadon CA, Choquette D, Esdaile JM. Prognostic factors in systemic necrotizing vasculitis of the polyarteritis nodosa group: a review of 45 cases. J Rheumatol 1995; 22: 78-84.
10. Guillevin L, Lhote F, Cohen P, Sauvaget F, Jarrousse B, Lortholary O, Noel LH, Trepo C. Polyarteritis nodosa related to hepatitis B virus. A prospective study with long-term observation of 41 patients. Medicine 1995; 74: 238-53.
11. Agard C, Mouthon L, Mahr A, Guillevin L. Microscopic polyangiitis and polyarteritis nodosa: how and when do they start? Arthritis Rheum 2003; 49: 709-15.
12. Lhote F, Guillevin L. Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome. Clinical aspects and treatment. Rheum Dis Clin North Am 1995; 21: 911-47.
13. Weyand CM, Goronzy JJ. Medium- and large-vessel vasculitis. N Engl J Med 2003; 349: 160-9.
14. Cupps TR, Fauci AS. The Vasculitides. Major Probl Intern Med 1981; 21: 1-211.
15. Langford CA. 15. Vasculitis. J Allergy Clin Immunol 2003; 111: S602-12.
16. Fauci AS. The vasculitis syndromes. In: Braunwald E, Isselbacher KI, Petersdorf RG, Wilson JD, Martin JB and Fauci AS, eds, Harrison's Principles of Internal Medicine 14th ed. New York, McGraw-Hill 1998: 1912-4.
17. Jennette JC, Falk RJ. Small-vessel vasculitis. N Engl J Med 1997; 337: 1512-23.
18. Savage CO, Harper L, Adu D. Primary systemic vasculitis. Lancet 1997; 349: 553-8.
19. Hoffman G, Specks U. Antineutrophil cytoplasmic antibodies. Arthritis Rheum 1998; 41: 1521-37.
20. Wright LF, Bicknell SL. Systemic necrotizing vasculitis presenting as epididymitis. J Urol 1986; 136: 1094.
21. Tanuma Y, Oda T, Yokoo A, Ito S, Takeuchi K. Recurrent polyarteritis nodosa limited to the testis. J Urol 2003; 170: 1953.
22. Karyn SE, Stephen JF, Jacob R. Polyarteritis nodosa presenting as hematuria and a testicular mass. J Urol 2001; 166: 624.
23. Mukamel E, Abarbanel J, Savion M, Konichezky M, Yachia D, Auslaender L. Testicular mass as a presenting symptom of isolated polyarteritis nodosa. Am J Clin Pathol 1995; 103: 215-7.
24. Sergent JS, Lockshin MD, Christian CL, Gocke DJ. Vasculitis with hepatitis B antigenemia: long-term observation in nine patients. Medicine (Baltimore) 1976; 55: 1-18.
25. Michault A, Faulques B, Sevadjan B, Troalen D, Marais A, Barau G. Prevalence of hepatitis A, B, C virus markers in Reunion (south hospital and Saint Pierre prison). Bull Soc Pathol Exot 2000; 93: 34-40.
26. Aker MI, Mast EE. The epidemiology of the viral hepatitis in the United States. Gastroenterol Clin North Am 1994; 23: 437-55.
27. Lepage L, Schiele F, Janot C, Siest G. Prevalence of viral hepatitis B markers in a sample population seen at a center of preventive medicine. Pathol Biol (Paris) 1986; 34: 851-4.
28. Hsu HM, Lu CF, Lee SC, Lin SR, Chen DS. Seroepidemiologic survey for hepatitis B virus infection in Taiwan: the effect of hepatitis B mass immunization. J Infect Dis 1999; 179: 367-70.
29. Furusyo N, Hayashi J, Sawayama Y, Kawakami Y, Kishihara Y, Kashiwagi S. The elimination of hepatitis B virus infection: changing seroepidemiology of hepatitis A and B virus infection in Okinawa, Japan over a 26-year period. Am J Trop Med Hyg 1998; 59: 693-8.
30. Andre F. Hepatitis B epidemiology in Asia, the Middle East and Africa. Vaccine 2000; 18 (Suppl 1): 20-2.
31. Joo KR, Bang S, Song B, Youn KH, Joo YH, Yang S, Kim KR, Chung Y, Lee YS, Suh DJ. Hepatitis B viral markers of Korean adults in the late 1990s: Survey data of 70,347 health screenees. Korean J Gastroenterol 1999; 33: 642-52.
32. Shurbaji MS, Epstein JI. Testicular vasculitis: Implications for systemic disease. Hum Pathol 1988; 19: 186-9.